A defective ABC transporter of the MRP family, responsible for the bean lpa1 mutation, affects the regulation of the phytic acid pathway, reduces seed myo ‐inositol and alters ABA sensitivity

By screening an EMS mutagenised common bean population, we had previously identified the lpa (low phytic acid) 280-10 line that carries a monogenic recessive mutation conferring a 90% reduction of InsP6 content and, differently from most other lpa mutants, does not display negative pleiotropic effects associated to the mutation. In the present work we mapped the lpa-280-10 mutation on bean chromosome 1, in a region syntenic to soybean (Glycine max) chromosomes 19 and 3, where the lpa mutant CX1834 was previously mapped and correlated to multi-drug resistance protein (MRP) type ATP-binding cassette (ABC) transporter gene orthologous to Arabidopsis AtMRP5/AtABCC5 and maize ZmMRP4 (lpa1). Fine mapping of bean lpa-280-10 and DNA sequencing data showed the occurrence of a single amino acid substitution (E to K) in the orthologous PvMRP-1 gene. We also provide data on a second MRP gene (PvMRP-2) present both in soybean and bean genomes, which, despite the high sequence identity (90%) and a very similar pattern of expression during seed development to PvMRP-1, is not able to complement the lpa mutation, suggesting that it may have a different role in the plant. Transcriptional and metabolic analysis of phytic acid pathway demonstrated the existence of a negative feedback mechanism of InsP6, or its degradation products, acting on genes coding for key enzymes of phytic acid pathway and leading to a 30% reduction of myo-inositol. Our results show that the reduced content of myo-inositol is responsible of the ABA hypersensitive response found in lpa-280-10 seed germination, indicating a key role of this metabolite in the multiple pleiotropic effects often reported for lpa mutants.